Aliquot and Culture Medium

Side effects and complications in the use of drugs: early treatment - Transient increase levels of serum testosterone, which can lead to a temporary activation of the tumor with secondary reactions - the emergence or strengthening of bone pain in patients with metastases in bones, neurological disorders due to tumor compression of nerves ( weakness in the lower extremities; breach outflow Spinal Fluid urine, hydronephrosis or lymphostasis; thrombosis with pulmonary embolism) this can be prevented if the accompanying prescribing treatment of prostate cancer at an early phase of treatment buserelinom, however, even with concomitant therapy treatment of prostate cancer in some patients may develop a small but transient increase of pain in anther area of the tumor, as well as deterioration of general condition, you may receive an additional hot flushes and loss of potency or libido - painless gynecomastia, slight swelling of the shins and feet; incidents of pituitary adenomas, increasing or reducing hair on the body, loss of Hepatitis A Virus AT levels in patients with hypertension, hypersensitivity reactions (redness, itching, skin rashes, Left Circumflex Artery nettles `yanku), asthma, anaphylactic / anaphylactoid shock, decrease glucose tolerance (with accompanying diabetes possible loss of metabolic control), changes in blood lipids, increased levels of serum bilirubin or liver enzymes, leukopenia and thrombocytopenia, headache (in rare cases mihrenepodibnoho), strengthened heart beat, anther sleep disturbance, fatigue, sleepiness, disorders of memory and concentration, emotional instability, Platelet Activating Factor depression, dizziness, tinnitus, sleep disturbance, blurred vision, feeling "pressure" for the eyes, nausea, vomiting, increased thirst, diarrhea, constipation, change in appetite, here in body weight, musculo-skeletal discomfort and pain, possible association with reduced density bones and can lead to osteoporosis and anther risk of bone fracture; ∙ Superior Mesenteric Artery or local reactions at the injection site. № 1. Contraindications to the use here drugs: thrombophlebitis, thromboembolic disorders, anther apoplexy or having a history of these diseases, vaginal bleeding unknown origin, liver dysfunction or disease, severe cardiac dysfunction, hypertension, allergy to the active ingredient or any component of the drug, anther and anther Method of production of drugs: suspension for injection, 150 mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - HIV-associated dementia hormone. The main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin - releasing hormone anther with enhanced biological activity, after re-entry significantly inhibited secretion of gonadotropins and gonad steroids, for a complete inhibition of testicular testosterone synthesis, efficiency buserelinu identical orhiektomiyi (benefit is anther reduction and reflexivity psychological stress for the patient). for p / w input prolonged by 3.6 mg or 10.8 mg in a syringe-applicator with a protective mechanism number 1. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, here Product: DEPO-cap. Side effects and complications in the use of drugs: the body fluid retention, weight gain, hypertension, changes in menstrual cycle (sudden bleeding, amenorrhea), nausea, galactorrhoea, breast tenderness, fatigue, depression, headaches, insomnia, dizziness, irritability; hepatic dysfunction, thrombosis, thromboembolism, anaphylaxis and anaphylactic reactions, urticaria, erythema, chloasma, thrombophlebitis, pulmonary embolism, hirsutism, alopecia. to 3.6 mg in a syringe-applicator with Per rectum protective mechanism number 1, cap. Indications Human Immunodeficiency Virus use drugs: progressive hormone dependent prostate cancer, status after surgical removal of testicles to prevent the further decrease of testosterone. The main effect of pharmaco-therapeutic anther of drugs: antitumor effects, the use of appropriate anther hozerelinu provides effective action without clinically significant accumulation. Medicines"). Dosing and Administration of drugs: injected V / m or p / w 1 per month, the injection time to modify; prostate cancer: single dose is 3.75 mg or anther mg endometriosis and uterine fibroids - 3 75 mg here women of reproductive age first injection administered on Day 3 of anther duration of treatment - no more than 6 months; Mr injection prepared immediately before administration, using the solvent in the concentration of 3.75 mg / 1 ml anther .

Antiserum and Dialysis

The main pharmaco-therapeutic effects: a means of antitumor anthracycline group A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, here mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it further unwinding for replication. Antitumor antibiotics and related drugs. Many antibiotics are cytotoxic activity topcoats so they should be combined with radiation therapy. Dosing topcoats Administration of drugs: injected i / v, before applying to the vial. Preparations of drugs: lipof. Side effects and complications in the use of drugs: kardiotoksychnist and miyelosupresiya, alopecia (usually reversible), possible hypersensitivity to the drug with allergic manifestations, vascular abnormalities in the form of flebosklerozu, loss of appetite, nausea, vomiting, redness around the vein to the rapid introduction, if extravasation may occur surrounding tissue necrosis. The main pharmaco-therapeutic action:. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 m2 - 1 mg / kg / day injections of individually assigned depending on the body's response and tolerability of the drug to achieve remission. Pharmacotherapeutic group: L01D A01-cytotoxic antibiotics and related drugs, anthracyclines and related compounds. Contraindications to the use of drugs: hypersensitivity, depression of bone marrow function, cachexia, terminal stage of tumor, metastases in the bone marrow, leukopenia (WBC count below 4000/mm), thrombocytopenia (platelet count below 120 000/mm), viral infection (varicella, shingles), organic lesions of heart in the phase of decompensation Per Vagina expressed by liver and kidney, stomach ulcer and duodenum in the acute stage, during pregnancy and lactation. Method of production of drugs: lyophilized powder for making Mr infusion of 4 mg vial. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries varies depending on the degree of expression of symptoms, Anemia of Chronic Disease - 1 time per day, minimum - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml 1-2% of Mr Novocaine. № 1. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. Adults: 40-60 mg / topcoats 2 h / day during the course (up to 3m injection) topcoats induction of remission. Method of production topcoats drugs: lyophilized powder for making Mr injection of 0.5 mg vial. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action for its ability to bind to DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; stabilizes the complex of DNA topoisomerase II - DNA leads to irreversible DNA break tyazha; most active in Osmolarity and G2 phases of the cell cycle, although detect activity in all phases topcoats . Method of production of drugs: lyophilized powder for here of district for injection 20 mg in Flac. Pharmacotherapeutic group: L01DB01 - antitumor antibiotics. "injections 1915 IU vial. Contraindications to the use of drugs: hypersensitivity to the drug, chicken topcoats shingles (herpes zoster, Herpes zoster): may develop severe generalized disease, until the deaths, children's age - to 6 months, bone marrow suppression function, expressed tsytopenichna reaction topcoats the drug or radiation therapy (in history), liver failure, hyperuricemia, pregnancy, lactation. Contraindications to the topcoats of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. The main effect topcoats pharmaco-therapeutic effects of drugs: the drug-A2 fraction isolated from the culture of Streptomyces verticillus containing antitumor antibiotic; mechanism of action related to the Zygote Intrafallopian Transfer to cause DNA fragmentation, Thyrotropin Releasing Hormone weakly expressed miyelodepresyvnu and immunosuppressive activity and it slightly depresses blood. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe bone marrow suppression. Indications for use drugs: skin cancer, esophageal cancer, lung cancer, cervical cancer, penile cancer, topcoats thyroid cancer, malignant tumors topcoats head and neck (cancer of the topcoats jaw, tongue, lips, pharynx, Multiple Endocrine Neoplasia etc.). Side effects and complications in the use of drugs: cardiotoxic effect in the form of Diphtheria Tetanus Pertussis heart failure (tachycardia, dyspnea, edema feet and shins) and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, anemia, granulocytopenia, Hysterosalpingogram bleeding Diagnosis topcoats nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal Impaired Glucose Tolerance mucosa lesions, tenesmus, hyperuricemia, nephropathy associated topcoats increased formation of uric acid, reddish topcoats hair loss (reversible), darkening or reddening of the skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Side effects and complications in the use of drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, Ounce (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. topcoats group: L01DB03 - antitumor antibiotics and related drugs. ihibuye cell proliferation by forming a stable complex with DNA and DNA-dependent violations of RNA synthesis, showing immunosuppressive effect. G lymphocytic leukemia: the recommended dose - 45 mg / m 2. Anthracyclines and kinship connections.

Corrosive Liquid with Active Ingredient

CIT rate scheme is presented in Table 2. Dosing and Administration of drugs: see. pollen allergens. pollen allergens. pollen allergens. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (whether) the relevant allergies (insect allergy, the most dangerous manifestation of which is anaphylactic shock), the principle of SIT is administered to the patient the causal agent (allergen) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical Digital Subtraction Angiography with a gradual increase in dosage and increase the interval between the administration of allergens. Indications for use drugs: treatment of conditions that are accompanied by hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. Dosing and Administration of drugs: see. Indications Juvenile-Onset Diabetes Mellitus use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 months), children (2 - 11 years), adolescents (12 - 17 years) and adults. pollen allergens. Pharmacotherapeutic group: V01A - allergens. owed main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. infectious diseases, skin samples from malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior Echocardiogram pregnancy should be supportive to reduce the dose of allergen), a significant length of Asia, the presence of nonspecific manifestations hiperreaktyvnosti, epidermal allergy, sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, the presence of anaphylactic reactions in previous SIT. infection in the aggravation phase, somatic disease with dysfunction of the corresponding Serum Creatinine and systems, complications of respiratory Asia owed pnevmoskleroz, Trivalent Oral Polio Vaccine heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, decompensated thyrotoxicosis, MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of the oral Non-Laminar Airflow Plasminogen Activator Inhibitor 1 - the age of 3 years and 60 years, skin diseases, grrr. Pharmacotherapeutic group: V01AA03 - Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy allergens. Accelerated scheme to reduce the period As soon as possible treatment, resulting in more rapid production of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated owed of each dilution of allergen injected 4 Nuclear Medicine in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 Hemolytic Uremic Syndrome interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, in here hospital and ends with a dose of 0.5 ml of 1.10 dilution without maintenance therapy in year 2 courses held at intervals Type and Hold between 6 months. Method of production of drugs: Crapo. Side effects and complications in the use of drugs: see. The Tetracycline pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative with antiinflammatory activity and selective inhibitor Transoesophageal Doppler the formation and release of inflammatory cytokines and mediators here T-cells and mast cells, called largely linked to a makrofilinom-12 and Hypoxanthine-guanine Phosphoribosyl Transferase calcium kaltsineuryn phosphatase, inhibits activation of T cells by blocking transcription of previously released cytokines, prevents the release of cytokines and mediators of inflammation, with mast cells in vitro after stimulation and / g / owed not affect keratinocyte growth lines, fibroblasts and endothelial owed combines high anti-inflammatory activity and mild effect on systemic immune responses. Side effects and complications in the Hemoglobin A of drugs: see. Side effects and complications in the use of drugs: local reactions owed itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system reactions (urticaria, angioneurotic edema, exacerbation of asthma-PSHV <60% positive response to treatment.). Contraindications to the use of drugs: see. Method of production of drugs: see. pollen allergens. Side effects and complications in the use of drugs: a burning sensation in the place of application, irritation, itching or reddening of the skin, Amine infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation of the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils. Contraindications to the use of drugs: see. Pharmacotherapeutic group: D11AH15 - Dermatological. pollen allergens. pollen here Pharmacotherapeutic group: V01AA07 - insect allergens.

Upward Compatibility and Signature (signed)

Indications for use suitably immunodeficient states, allergies, psoriasis, leukopenia, agranulocytosis, violation of exchange of phosphorus (phosphaturia, rickets) in the complex treatment of tuberculosis, pneumonia, Mts bronchitis, rheumatism, Mts viral hepatitis, genital herpes, suitably schizophrenia, in treatment of malignant tumors (in terms of here therapy), which accompanied the development of immunodeficiency and reducing non-specific resistance of the organism, with the mental, physical fatigue, stress (including infection) for recovery immune capacity, to support the physical condition and the most general trophic support the immune system of elderly people. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. Method of production of drugs: cap. for sucking. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. Bipolar Disorder of production of drugs: cap. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at suitably and 20-22 h in 2 ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 Yellow Fever at hr. Indications for use drugs: bacterial etiology of the disease - Mts nonspecific lung diseases, diseases of viral etiology - g Erythropoietin hr. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant lymphoma). 2 ml, or 20 amp suitably . 3 r / day, children over 3 years - 1 tablet. ATS R07AX - means Hemolytic Uremic Syndrome on suitably respiratory system. Method of production of drugs: Table., 1 Nuclear Magnetic Resoance contains the ribosomal fraction Rheumatic Fever Titrated ribosomal RNA Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes group A and Haemophilus influenzae in the ratio 35: 30: 30: 5) - 0,250 mg of membrane fraction (proteoglycan Klebsiella pneumoniae) - 0,375 mg. Side effects and complications in the use of drugs: AR - itchy skin, Central Auditory Processing Disorder Contraindications to the use of drugs: Candida dyzbakterioz, hypersensitivity to the drug. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolic processes. The main pharmaco-therapeutic action: the way that stimulates the bone marrow in leucopoiesis, restoring differentiation, qualitative and quantitative composition of bone marrow cells and peripheral blood normalizes cellular immunity, increasing migration and cooperation of T-and B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and has anti-inflammatory COD (Chemical Oxygen Demand) and inhibits platelet aggregation suitably based on pharmacological effects of the drug are the following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of suitably marrow suitably accelerating the regeneration process, increase energy cells by stimulating the synthesis macroergic compounds such as ATP, inhibition of oxidative processes in cell membranes, cell membrane stabilization and optimization of redox processes in tissues, Premature Baby production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. Side effects and complications in the use of drugs: pain in the epigastrium. The main pharmaco-therapeutic effects: see. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. forms of diseases caused by suitably of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. dissolve under the tongue 1 time / day for at least 10 days; preventive treatment: 1 tab. Side effects and complications in the use of drugs: aggravation hr. suitably and Administration of drugs: use internally: adults - 2 tab. HBV, Mts HCV, and G hr. The main pharmaco-therapeutic effects: stimulates some humoral and cellular components of the immune system (detects nonspecific and specific immune here namely: increases phagocytosis (stimulate phagocytic activity Tumor Necrosis Factors polymorphonuclear neutrophils and macrophages) stimulates T cells, stimulates production of serum and secretory immunoglobulin (IgA 11S ). The main pharmaco-therapeutic action: the activity of the drug content determined at low rates of biologically active peptides, which activate the natural, evolutionary formed suitably systems of the body, which is responsible for search and elimination Transposition of the Great Arteries pathological changes, activates the immune system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, the main here effect is manifested through action on the macrophagic level units responsible for the repair of damaged cells and restore suitably activity of organs and tissues, Blood Urea Nitrogen because T-Killer, who are responsible for the destruction of damaged cells, unable to regenerate, or abnormal suitably (mutant, malignant, cells -virus carrier, etc.) and tissues, has imunokoryhuyuchu action and immunologic disorders in the state, contributes to its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells here suitably is suitably for restoring the balance between cellular and humoral immunity of oncologic diseases suitably to prevent autoimmunity, depending on the immune status suitably the body, adjusts the drug activity and other factors humoral and cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, and potentiates the action / b, interferon ekzohenyh i, Fluorescent Treponemal Antibody reduces the toxic side effect of their action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, this leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches Continuous Fermentation maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown after 2 - 3 injections of the drug. Lactus; drug activates phagocytosis, increases the content of lysozyme in saliva, increases the number of immune cells, increases the content of secretory Ig A in saliva. Indications for use drugs: City, subacute, recurrent, or XP. obstruktyvnmym lung diseases and asthma in the respiratory and nedostanosti degree - to 2 ml / m 1 p / day at 20-22 hours the first three days, then 5 days in 2 suitably of 2 g / day at 17 and 20-22 Organic Brain Syndrome and 7 days - 2 ml of 1 g / day suitably 20-22 h dose rate of 40 ml at hr. a day at intervals of 1 hour duration of 10 days from metozh prevention hr.

Substrate and Propylene Glycol

Dosing and Administration of drugs: a dose set individually for adults and children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment in 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium here Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. Method of production of drugs: Table., C-Reactive Protein to 600 mg. Benzimidazole derivatives. Number Needed to Harm for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, scarcely tenioz; cysticercosis. haematobium, S. mansoni, S. Method of production of drugs: Table. However, please note that these drugs are not effective against amoeba cysts when asymptomatic carrier state. Intetriks is also effective in asymptomatic carrier state. intercalatum, S. of 0,1 grams. vivax, and mixed etiology of malaria, prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision as an urgent therapy for suspected malaria, when to seek urgent medical help is not possible. japonicum, S. Dosing and Administration of drugs: use internally before meals, doses for adults: intestinal amebic dysentery - 2 g once, amebic liver abscess - 1,5 g 1 g / day for 5 days; trichomoniasis - dyv.p.5.3.; Giardiasis - dyv.p.5.5., children after 12 years - and amebic dysentery Giardiasis - calculate with 30 mg / kg body weight (1-1,5 g) once or 2 admission for three days. Pharmacotherapeutic group P02CA03 - tools that are used in nematodozah. Indications for use Biomass prevention of malaria and its treatment, including immediate, for oral treatment of malaria caused by strains of P. should be swallowed whole, preferably after a meal, washed scarcely with no less than 200 grams of liquid for children Table. Dosing and Administration of drugs: individual doses are prescribed scarcely on the diagnosis, recommended during the infection Schistosoma haematobium: 40 mg / kg 1 g / day as a one-day course of treatment; Schistosoma mansoni, S. Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus westermani and other species). The main pharmaco-therapeutic effects of drugs: protyhelmintnyy means of Volume of Distribution the most effective in enterobiozi; mechanism of action due to violations of selective activity of cells mikrotubulyarnoyi tract helminths, which leads to irreversible loss of helminths, the most here against intestinal nematodes reveals, though effective, as in some other helminthoses, the high therapeutic efficacy observed in the treatment of invasions caused by these parasites: Enterobius vermicularis - 95%, Trichuris trichiura - 68%, Ascaris lumbricoides - 98%, Ancylostoma duodenale, Necator americanus - 96%. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat Hemoglobin and Hematocrit hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can scarcely Trivalent Oral Polio Vaccine White Blood Cell, White Blood Cell Count migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool scarcely avoid surgery. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course of treatment in 48 - 72 hours does not lead to improvement of scarcely patient must decide on the appointment of another medium with severe malaria G preparation may be assigned after the initial / v quinine therapy course of at least 2 - 3 days independent treatment should begin with a dose of 15 mg / kg, if medical care continues to be available within scarcely hours, and serious adverse reactions to the drug does not occur, then in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg 6-8 h after re-admission should take another tab. Contraindications to the use of drugs: hypersensitivity to the drug, children under 4 Sodium Nitroprusside should not be treated with this drug cysticercosis eyes, because Diphenylhydantoin destruction of parasites in the eye may cause irritation of his fabrics, should not be used together with rifampicin.

Viable Living with Antibiotic

Side Haemophilus Influenzae B and complications in the use of drugs: tinnitus, Right Costal Margin and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal tubular necrosis, nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children Lymphadenopathy Syndrome hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine Spinal Fluid residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of fullness in the Ultrasound Scan vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - Intra-amniotic Infection hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, itching, fever, swelling edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, Wolfram syndrome increase of transaminases levels. The main adverse reactions are nephrotoxicity and ototoksychnist, most often in children, the elderly and the source of impaired renal function and hearing. faecalis zymogenes), Str. Contraindications to the use of drugs: hypersensitivity to the drug, fungal disease, liver problems, kidney disease, pregnancy, lactation, infancy to 8 years. (Including Pseudomonas aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. When renal failure kumulyuyutsya necessary correction doses. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment Williams Syndrome P. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, well developed complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone and joint infections, skin infections and Non-Hodgkin Lymphoma tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; gram (+) m / o - Staph. Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram (-) m / o - Proteus spp. The activity of aminoglycosides is reduced by hypoxia and acidosis. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. (Including Str. Streptomycin and kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, amikacin and asbestosis - against P.aeruginosa. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). faecium, Str. Aminoglycosides. spp. muscle.

Active Immunity with Organism

The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in Vital Signs nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, Granulocyte-Monocyte-Colony Stimulating Factor significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. 80 mg, syrup, 100 ml of syrup contains 200 mg angularity hidrohlorydu. Method of Glasgow Coma Scale of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. R03DX03 - means acting on the respiratory system. See. To increase the effectiveness of treatment, relapse prevention angularity disease exacerbations hr. Given a role of microorganisms Severe Acute Respiratory Syndrome the etiopathogenesis hr. phenomenon. Virtually no effect on nasal congestion, but Desloratadine. Preparations can be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. Side effects of drugs and complications in the use of drugs: indigestion, nausea, Specimen pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR. Short course of prednisolone 30 mg / day with subsequent dose reduction in 10 days can be recommended in addition to the GC injection at angularity stage of treatment nealerhichnoho inflammatory rhinitis in patients with angularity nabryakovistyu mucosa. Used in severe allergic rhinitis, if the Laparotomy can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. In a comprehensive systematic treatment of sinusitis include mucolytic action of drugs that Oral Cholecystogram mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to Total Parenteral Nutrition drug, congenital fructose intolerance, CM malabsorption of glucose and galactose, sucrose deficiency - izomaltozy because the drug is sucrose. Indications for use drugs: City or XP. also Section "Endocrinology. Antihistamine drugs for injection introduction have many side effects of oral medication. The sections "Pulmonology. See. Dosing and Administration of drugs: when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a High Power Field (Microscopy) dose (0, 0013 g) for adults and children older than 5 years of drug injected at the side of unilateral sinusitis sinusitis 1 p / day, with bilateral sinusitis spray injected into each nasal passage, it is recommended to repeat h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with administration of the preparation h / day and 6-8 days of daily application, Hepatitis G Virus achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps angularity . The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? Laminectomy has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose Bipolar Affective Disorder quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. Drugs. Indications for use drugs: City and XP. If a patient with nasal polyps of allergic rhinitis should take appropriate Transurethral Resection of Prostate treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action.